The ATI Programme funds industrial research and investment aid for research infrastructures to make the UK civil aerospace sector more competitive.
Funding opportunity sorting options
33 opportunities found using the current filters, sorted by publication date
Funding opportunity list
UK registered businesses can apply for a share of up to £4.35 million for collaborative research and development (R&D) projects related to hydrogen storage and distribution supply chain.
Organisations can apply for a share of up to £10 million in total across the 3 stages, to create new or improved clean energy access in:
- sub-Saharan Africa
- South Asia
- the Indo-Pacific regions
UK registered businesses can apply for a share of up to £5 million for the purpose of developing innovative proposals with Singapore.
Organisations can apply for a share of £5 million inclusive of VAT to deliver innovations addressing key drug related overdose priorities across 2 competitions.
Organisations can apply for a share of £1 million, inclusive of VAT, to develop innovative solutions that increase access for small and medium sized enterprises and the self-employed to occupational health services.
Establish an interdisciplinary Net Zero Transport for a Resilient Future Research Hub, focusing on climate adaptation and mitigation solutions for our transport system.
A joint programme between UKRI and DfT as part of the UKRI ‘building a green future’ strategic theme.
UK registered organisations can apply for a share of up to £25 million for game-changing and commercially viable research and development (R&D) innovations that can significantly impact the UK economy. This funding is from Innovate UK, part of UK Research and Innovation.
UK registered organisations can apply for a share of up to £4 million for collaborative research projects resulting in innovative solutions.
You must collaborate with at least 1 German small or medium-sized enterprise (SME) applying under the equivalent German Central Innovation Programme for SMEs (ZIM).
UK registered organisations can apply for a share of up to £5 million.
This is to support innovation in intracellular drug delivery formulations.